Biotech | March 07, 2022
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
High level of vaccine efficacy maintained over a 6-month period of surveillance
Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m
Cantex also plans to initiate Phase 2 clinical trials exploring the therapeutic effect of azeliragon in pancreatic and breast cancers.
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
Study to evaluate effectiveness of hypoglossal nerve stimulation
Eubio Isoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin.
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
Subscribe To Our Newsletter & Stay Updated
